 | • レポートコード：MRC2012B0856 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、吐き気・嘔吐治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。吐き気・嘔吐治療の種類別市場規模（セロトニン受容体拮抗薬、ニューロキニンNK1受容体拮抗薬、その他）、用途別市場規模（CINV、PONV、乗り物酔い、妊娠、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Merck & Co. Inc.、Taiji group、Kyowa Kirin、Helsinn Group、Teva Pharmaceutical Industries Ltd.、Unimed Pharmaceuticals (AbbVie Inc.)、Heron Therapeutics、Qilu Pharma、Sanofi、Novartis、Atnahs Pharma UK Limited、Tesaro、Mylan、Duchesnay、 ・地域別グローバル市場分析 2015年-2020年 ・吐き気・嘔吐治療の北米市場（アメリカ、カナダ、メキシコ） ・吐き気・嘔吐治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・吐き気・嘔吐治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・吐き気・嘔吐治療の南米市場（ブラジル、アルゼンチン） ・吐き気・嘔吐治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：セロトニン受容体拮抗薬、ニューロキニンNK1受容体拮抗薬、その他 ・用途別分析：CINV、PONV、乗り物酔い、妊娠、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Nausea And Vomiting Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Nausea And Vomiting Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.2%% in the forecast period of 2020 to 2025 and will expected to reach USD 6050.7 million by 2025, from USD 4753.1 million in 2019.
Market segmentation
Nausea And Vomiting Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Nausea And Vomiting Treatment market has been segmented into:
Serotonin Receptor Antagonist
Neurokinin NK1 Receptor Antagonist
Other
By Application, Nausea And Vomiting Treatment has been segmented into:
CINV
PONV
Motion Sickness
Pregnancy
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Nausea And Vomiting Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Nausea And Vomiting Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Nausea And Vomiting Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Nausea And Vomiting Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Nausea And Vomiting Treatment Market Share Analysis
Nausea And Vomiting Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Nausea And Vomiting Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Nausea And Vomiting Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Nausea And Vomiting Treatment are:
Merck & Co. Inc.
Taiji group
Kyowa Kirin
Helsinn Group
Teva Pharmaceutical Industries Ltd.
Unimed Pharmaceuticals (AbbVie Inc.)
Heron Therapeutics
Qilu Pharma
Sanofi
Novartis
Atnahs Pharma UK Limited
Tesaro
Mylan
Duchesnay
Among other players domestic and global, Nausea And Vomiting Treatment market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Nausea And Vomiting Treatment Market Overview
1.1 Product Overview and Scope of Nausea And Vomiting Treatment
1.2 Classification of Nausea And Vomiting Treatment by Type
1.2.1 Global Nausea And Vomiting Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Nausea And Vomiting Treatment Revenue Market Share by Type in 2019
1.2.3 Serotonin Receptor Antagonist
1.2.4 Neurokinin NK1 Receptor Antagonist
1.2.5 Other
1.3 Global Nausea And Vomiting Treatment Market by Application
1.3.1 Overview: Global Nausea And Vomiting Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 CINV
1.3.3 PONV
1.3.4 Motion Sickness
1.3.5 Pregnancy
1.3.6 Others
1.4 Global Nausea And Vomiting Treatment Market by Regions
1.4.1 Global Nausea And Vomiting Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Nausea And Vomiting Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Nausea And Vomiting Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Nausea And Vomiting Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Nausea And Vomiting Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Nausea And Vomiting Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Nausea And Vomiting Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Merck & Co. Inc.
2.1.1 Merck & Co. Inc. Details
2.1.2 Merck & Co. Inc. Major Business
2.1.3 Merck & Co. Inc. SWOT Analysis
2.1.4 Merck & Co. Inc. Product and Services
2.1.5 Merck & Co. Inc. Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Taiji group
2.2.1 Taiji group Details
2.2.2 Taiji group Major Business
2.2.3 Taiji group SWOT Analysis
2.2.4 Taiji group Product and Services
2.2.5 Taiji group Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Kyowa Kirin
2.3.1 Kyowa Kirin Details
2.3.2 Kyowa Kirin Major Business
2.3.3 Kyowa Kirin SWOT Analysis
2.3.4 Kyowa Kirin Product and Services
2.3.5 Kyowa Kirin Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Helsinn Group
2.4.1 Helsinn Group Details
2.4.2 Helsinn Group Major Business
2.4.3 Helsinn Group SWOT Analysis
2.4.4 Helsinn Group Product and Services
2.4.5 Helsinn Group Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Teva Pharmaceutical Industries Ltd.
2.5.1 Teva Pharmaceutical Industries Ltd. Details
2.5.2 Teva Pharmaceutical Industries Ltd. Major Business
2.5.3 Teva Pharmaceutical Industries Ltd. SWOT Analysis
2.5.4 Teva Pharmaceutical Industries Ltd. Product and Services
2.5.5 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Unimed Pharmaceuticals (AbbVie Inc.)
2.6.1 Unimed Pharmaceuticals (AbbVie Inc.) Details
2.6.2 Unimed Pharmaceuticals (AbbVie Inc.) Major Business
2.6.3 Unimed Pharmaceuticals (AbbVie Inc.) Product and Services
2.6.4 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Heron Therapeutics
2.7.1 Heron Therapeutics Details
2.7.2 Heron Therapeutics Major Business
2.7.3 Heron Therapeutics Product and Services
2.7.4 Heron Therapeutics Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 Qilu Pharma
2.8.1 Qilu Pharma Details
2.8.2 Qilu Pharma Major Business
2.8.3 Qilu Pharma Product and Services
2.8.4 Qilu Pharma Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 Sanofi
2.9.1 Sanofi Details
2.9.2 Sanofi Major Business
2.9.3 Sanofi Product and Services
2.9.4 Sanofi Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.10 Novartis
2.10.1 Novartis Details
2.10.2 Novartis Major Business
2.10.3 Novartis Product and Services
2.10.4 Novartis Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.11 Atnahs Pharma UK Limited
2.11.1 Atnahs Pharma UK Limited Details
2.11.2 Atnahs Pharma UK Limited Major Business
2.11.3 Atnahs Pharma UK Limited Product and Services
2.11.4 Atnahs Pharma UK Limited Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.12 Tesaro
2.12.1 Tesaro Details
2.12.2 Tesaro Major Business
2.12.3 Tesaro Product and Services
2.12.4 Tesaro Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.13 Mylan
2.13.1 Mylan Details
2.13.2 Mylan Major Business
2.13.3 Mylan Product and Services
2.13.4 Mylan Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.14 Duchesnay
2.14.1 Duchesnay Details
2.14.2 Duchesnay Major Business
2.14.3 Duchesnay Product and Services
2.14.4 Duchesnay Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Nausea And Vomiting Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Nausea And Vomiting Treatment Players Market Share
3.2.2 Top 10 Nausea And Vomiting Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Nausea And Vomiting Treatment Revenue and Market Share by Regions
4.2 North America Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
5 North America Nausea And Vomiting Treatment Revenue by Countries
5.1 North America Nausea And Vomiting Treatment Revenue by Countries (2015-2020)
5.2 USA Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
6 Europe Nausea And Vomiting Treatment Revenue by Countries
6.1 Europe Nausea And Vomiting Treatment Revenue by Countries (2015-2020)
6.2 Germany Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
6.4 France Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Nausea And Vomiting Treatment Revenue by Countries
7.1 Asia-Pacific Nausea And Vomiting Treatment Revenue by Countries (2015-2020)
7.2 China Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
7.5 India Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
8 South America Nausea And Vomiting Treatment Revenue by Countries
8.1 South America Nausea And Vomiting Treatment Revenue by Countries (2015-2020)
8.2 Brazil Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Nausea And Vomiting Treatment by Countries
9.1 Middle East & Africa Nausea And Vomiting Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Nausea And Vomiting Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Nausea And Vomiting Treatment Market Forecast by Type (2019-2024)
10.3 Serotonin Receptor Antagonist Revenue Growth Rate (2015-2025)
10.4 Neurokinin NK1 Receptor Antagonist Revenue Growth Rate (2015-2025)
10.5 Other Revenue Growth Rate (2015-2025)
11 Global Nausea And Vomiting Treatment Market Segment by Application
11.1 Global Nausea And Vomiting Treatment Revenue Market Share by Application (2015-2020)
11.2 Nausea And Vomiting Treatment Market Forecast by Application (2019-2024)
11.3 CINV Revenue Growth (2015-2020)
11.4 PONV Revenue Growth (2015-2020)
11.5 Motion Sickness Revenue Growth (2015-2020)
11.6 Pregnancy Revenue Growth (2015-2020)
11.7 Others Revenue Growth (2015-2020)
12 Global Nausea And Vomiting Treatment Market Size Forecast (2021-2025)
12.1 Global Nausea And Vomiting Treatment Market Size Forecast (2021-2025)
12.2 Global Nausea And Vomiting Treatment Market Forecast by Regions (2021-2025)
12.3 North America Nausea And Vomiting Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Nausea And Vomiting Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Nausea And Vomiting Treatment Revenue Market Forecast (2021-2025)
12.6 South America Nausea And Vomiting Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Nausea And Vomiting Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Nausea And Vomiting Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Nausea And Vomiting Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Nausea And Vomiting Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Nausea And Vomiting Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Nausea And Vomiting Treatment Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Merck & Co. Inc. Corporate Information, Location and Competitors
Table 7. Merck & Co. Inc. Nausea And Vomiting Treatment Major Business
Table 8. Merck & Co. Inc. Nausea And Vomiting Treatment Total Revenue (USD Million) (2017-2018)
Table 9. Merck & Co. Inc. SWOT Analysis
Table 10. Merck & Co. Inc. Nausea And Vomiting Treatment Product and Solutions
Table 11. Merck & Co. Inc. Nausea And Vomiting Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Taiji group Corporate Information, Location and Competitors
Table 13. Taiji group Nausea And Vomiting Treatment Major Business
Table 14. Taiji group Nausea And Vomiting Treatment Total Revenue (USD Million) (2018-2019)
Table 15. Taiji group SWOT Analysis
Table 16. Taiji group Nausea And Vomiting Treatment Product and Solutions
Table 17. Taiji group Nausea And Vomiting Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Kyowa Kirin Corporate Information, Location and Competitors
Table 19. Kyowa Kirin Nausea And Vomiting Treatment Major Business
Table 20. Kyowa Kirin Nausea And Vomiting Treatment Total Revenue (USD Million) (2017-2018)
Table 21. Kyowa Kirin SWOT Analysis
Table 22. Kyowa Kirin Nausea And Vomiting Treatment Product and Solutions
Table 23. Kyowa Kirin Nausea And Vomiting Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Helsinn Group Corporate Information, Location and Competitors
Table 25. Helsinn Group Nausea And Vomiting Treatment Major Business
Table 26. Helsinn Group Nausea And Vomiting Treatment Total Revenue (USD Million) (2017-2018)
Table 27. Helsinn Group SWOT Analysis
Table 28. Helsinn Group Nausea And Vomiting Treatment Product and Solutions
Table 29. Helsinn Group Nausea And Vomiting Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Teva Pharmaceutical Industries Ltd. Corporate Information, Location and Competitors
Table 31. Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Major Business
Table 32. Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Total Revenue (USD Million) (2017-2018)
Table 33. Teva Pharmaceutical Industries Ltd. SWOT Analysis
Table 34. Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Product and Solutions
Table 35. Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Unimed Pharmaceuticals (AbbVie Inc.) Corporate Information, Location and Competitors
Table 37. Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Major Business
Table 38. Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Total Revenue (USD Million) (2017-2018)
Table 39. Unimed Pharmaceuticals (AbbVie Inc.) SWOT Analysis
Table 40. Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Product and Solutions
Table 41. Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Heron Therapeutics Corporate Information, Location and Competitors
Table 43. Heron Therapeutics Nausea And Vomiting Treatment Major Business
Table 44. Heron Therapeutics Nausea And Vomiting Treatment Total Revenue (USD Million) (2017-2018)
Table 45. Heron Therapeutics SWOT Analysis
Table 46. Heron Therapeutics Nausea And Vomiting Treatment Product and Solutions
Table 47. Heron Therapeutics Nausea And Vomiting Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Qilu Pharma Corporate Information, Location and Competitors
Table 49. Qilu Pharma Nausea And Vomiting Treatment Major Business
Table 50. Qilu Pharma Nausea And Vomiting Treatment Total Revenue (USD Million) (2017-2018)
Table 51. Qilu Pharma SWOT Analysis
Table 52. Qilu Pharma Nausea And Vomiting Treatment Product and Solutions
Table 53. Qilu Pharma Nausea And Vomiting Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Sanofi Corporate Information, Location and Competitors
Table 55. Sanofi Nausea And Vomiting Treatment Major Business
Table 56. Sanofi Nausea And Vomiting Treatment Total Revenue (USD Million) (2017-2018)
Table 57. Sanofi SWOT Analysis
Table 58. Sanofi Nausea And Vomiting Treatment Product and Solutions
Table 59. Sanofi Nausea And Vomiting Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Novartis Corporate Information, Location and Competitors
Table 61. Novartis Nausea And Vomiting Treatment Major Business
Table 62. Novartis Nausea And Vomiting Treatment Total Revenue (USD Million) (2017-2018)
Table 63. Novartis SWOT Analysis
Table 64. Novartis Nausea And Vomiting Treatment Product and Solutions
Table 65. Novartis Nausea And Vomiting Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Atnahs Pharma UK Limited Corporate Information, Location and Competitors
Table 67. Atnahs Pharma UK Limited Nausea And Vomiting Treatment Major Business
Table 68. Atnahs Pharma UK Limited Nausea And Vomiting Treatment Total Revenue (USD Million) (2017-2018)
Table 69. Atnahs Pharma UK Limited SWOT Analysis
Table 70. Atnahs Pharma UK Limited Nausea And Vomiting Treatment Product and Solutions
Table 71. Atnahs Pharma UK Limited Nausea And Vomiting Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Tesaro Corporate Information, Location and Competitors
Table 73. Tesaro Nausea And Vomiting Treatment Major Business
Table 74. Tesaro Nausea And Vomiting Treatment Total Revenue (USD Million) (2017-2018)
Table 75. Tesaro SWOT Analysis
Table 76. Tesaro Nausea And Vomiting Treatment Product and Solutions
Table 77. Tesaro Nausea And Vomiting Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Mylan Corporate Information, Location and Competitors
Table 79. Mylan Nausea And Vomiting Treatment Major Business
Table 80. Mylan Nausea And Vomiting Treatment Total Revenue (USD Million) (2017-2018)
Table 81. Mylan SWOT Analysis
Table 82. Mylan Nausea And Vomiting Treatment Product and Solutions
Table 83. Mylan Nausea And Vomiting Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Duchesnay Corporate Information, Location and Competitors
Table 85. Duchesnay Nausea And Vomiting Treatment Major Business
Table 86. Duchesnay Nausea And Vomiting Treatment Total Revenue (USD Million) (2017-2018)
Table 87. Duchesnay SWOT Analysis
Table 88. Duchesnay Nausea And Vomiting Treatment Product and Solutions
Table 89. Duchesnay Nausea And Vomiting Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Global Nausea And Vomiting Treatment Revenue (Million USD) by Players (2015-2020)
Table 91. Global Nausea And Vomiting Treatment Revenue Share by Players (2015-2020)
Table 92. Global Nausea And Vomiting Treatment Revenue (Million USD) by Regions (2015-2020)
Table 93. Global Nausea And Vomiting Treatment Revenue Market Share by Regions (2015-2020)
Table 94. North America Nausea And Vomiting Treatment Revenue by Countries (2015-2020)
Table 95. North America Nausea And Vomiting Treatment Revenue Market Share by Countries (2015-2020)
Table 96. Europe Nausea And Vomiting Treatment Revenue (Million USD) by Countries (2015-2020)
Table 97. Asia-Pacific Nausea And Vomiting Treatment Revenue (Million USD) by Countries (2015-2020)
Table 98. South America Nausea And Vomiting Treatment Revenue by Countries (2015-2020)
Table 99. South America Nausea And Vomiting Treatment Revenue Market Share by Countries (2015-2020)
Table 100. Middle East and Africa Nausea And Vomiting Treatment Revenue (Million USD) by Countries (2015-2020)
Table 101. Middle East and Africa Nausea And Vomiting Treatment Revenue Market Share by Countries (2015-2020)
Table 102. Global Nausea And Vomiting Treatment Revenue (Million USD) by Type (2015-2020)
Table 103. Global Nausea And Vomiting Treatment Revenue Share by Type (2015-2020)
Table 104. Global Nausea And Vomiting Treatment Revenue Forecast by Type (2021-2025)
Table 105. Global Nausea And Vomiting Treatment Revenue by Application (2015-2020)
Table 106. Global Nausea And Vomiting Treatment Revenue Share by Application (2015-2020)
Table 107. Global Nausea And Vomiting Treatment Revenue Forecast by Application (2021-2025)
Table 108. Global Nausea And Vomiting Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Nausea And Vomiting Treatment Picture
Figure 2. Global Nausea And Vomiting Treatment Revenue Market Share by Type in 2019
Figure 3. Serotonin Receptor Antagonist Picture
Figure 4. Neurokinin NK1 Receptor Antagonist Picture
Figure 5. Other Picture
Figure 6. Nausea And Vomiting Treatment Revenue Market Share by Application in 2019
Figure 7. CINV Picture
Figure 8. PONV Picture
Figure 9. Motion Sickness Picture
Figure 10. Pregnancy Picture
Figure 11. Others Picture
Figure 12. Global Nausea And Vomiting Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Nausea And Vomiting Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Nausea And Vomiting Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Nausea And Vomiting Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Nausea And Vomiting Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Nausea And Vomiting Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Nausea And Vomiting Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Nausea And Vomiting Treatment Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Nausea And Vomiting Treatment Revenue Market Share in 2019
Figure 21. Global Top 10 Players Nausea And Vomiting Treatment Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Nausea And Vomiting Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Nausea And Vomiting Treatment Revenue Market Share by Regions (2015-2020)
Figure 25. Global Nausea And Vomiting Treatment Revenue Market Share by Regions in 2018
Figure 26. North America Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
Figure 27. Europe Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
Figure 29. South America Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
Figure 31. North America Nausea And Vomiting Treatment Revenue Market Share by Countries (2015-2020)
Figure 32. North America Nausea And Vomiting Treatment Revenue Market Share by Countries in 2019
Figure 33. USA Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
Figure 34. Canada Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
Figure 36. Europe Nausea And Vomiting Treatment Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Nausea And Vomiting Treatment Revenue Market Share by Countries in 2019
Figure 38. Germany Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
Figure 39. UK Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
Figure 40. France Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
Figure 41. Russia Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
Figure 42. Italy Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Nausea And Vomiting Treatment Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Nausea And Vomiting Treatment Revenue Market Share by Countries in 2019
Figure 45. China Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
Figure 46. Japan Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
Figure 47. Korea Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
Figure 48. India Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
Figure 50. South America Nausea And Vomiting Treatment Revenue Market Share by Countries (2015-2020)
Figure 51. South America Nausea And Vomiting Treatment Revenue Market Share by Countries in 2019
Figure 52. Brazil Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Nausea And Vomiting Treatment Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Nausea And Vomiting Treatment Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
Figure 57. UAE Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Nausea And Vomiting Treatment Revenue and Growth Rate (2015-2020)
Figure 60. Global Nausea And Vomiting Treatment Revenue Share by Type (2015-2020)
Figure 61. Global Nausea And Vomiting Treatment Revenue Share by Type in 2019
Figure 62. Global Nausea And Vomiting Treatment Market Share Forecast by Type (2021-2025)
Figure 63. Global Serotonin Receptor Antagonist Revenue Growth Rate (2015-2020)
Figure 64. Global Neurokinin NK1 Receptor Antagonist Revenue Growth Rate (2015-2020)
Figure 65. Global Other Revenue Growth Rate (2015-2020)
Figure 66. Global Nausea And Vomiting Treatment Revenue Share by Application (2015-2020)
Figure 67. Global Nausea And Vomiting Treatment Revenue Share by Application in 2019
Figure 68. Global Nausea And Vomiting Treatment Market Share Forecast by Application (2021-2025)
Figure 69. Global CINV Revenue Growth Rate (2015-2020)
Figure 70. Global PONV Revenue Growth Rate (2015-2020)
Figure 71. Global Motion Sickness Revenue Growth Rate (2015-2020)
Figure 72. Global Pregnancy Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Nausea And Vomiting Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Nausea And Vomiting Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Nausea And Vomiting Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Nausea And Vomiting Treatment Revenue Market Forecast (2021-2025)
Figure 78. Europe Nausea And Vomiting Treatment Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Nausea And Vomiting Treatment Revenue Market Forecast (2021-2025)
Figure 80. South America Nausea And Vomiting Treatment Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Nausea And Vomiting Treatment Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
術後悪心嘔吐（PONV）の世界市場（～2026年） The global post-operative nausea and vomiting (PONV) market is growing at a significant rate due to bourgeoning incidence rate of post-operative complications and increasing demand for combination therapy, as well as introduction of promising drugs in this segment across the globe. Major factors boo…- 化学療法誘発性悪心・嘔吐（CINV）の世界市場（～2026年） Chemotherapy-Induced Nausea and Vomiting (CINV) is one of the devastating side effects for patients undergoing cancer treatment. It is caused when various types of poisonous substances such as chemotherapeutic agents enter in the human body and alert the digestive system during chemotherapy. Besides…
- 化学療法誘発性悪心・嘔吐（CINV）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market The global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Chemoth…
- 化学療法誘発性悪心・嘔吐（CINV）治療薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market pl…
- 吐き気薬の世界市場（～2026年） Nausea is an unpleasant, diffuse sensation of unease and discomfort, often perceived as an urge to vomit. While not painful, it can be a debilitating symptom if prolonged, and has been described as placing discomfort on the chest, upper abdomen, or back of the throat. Many pharmacologic medications …